Kiniksa Pharmaceuticals International Plc (KNSA)
41.83
+0.80
(+1.95%)
USD |
NASDAQ |
Jan 21, 16:00
41.00
-0.83
(-1.98%)
Pre-Market: 09:03
Kiniksa Pharmaceuticals International Free Cash Flow: 101.73M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -14.82M |
| NovoCure Ltd. | -65.17M |
| LivaNova Plc | 191.43M |
| ADMA Biologics, Inc. | 40.61M |
| Akanda Corp. | -2.518M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 33.68M |
| Cash from Investing (Quarterly) | -62.76M |
| Cash from Financing (Quarterly) | 11.90M |
| Free Cash Flow Per Share (Quarterly) | 0.4124 |
| Free Cash Flow to Equity (Quarterly) | 33.05M |
| Free Cash Flow to Firm (Quarterly) | 33.01M |
| Free Cash Flow Yield | 3.17% |